siRNA agents inhibit oncogene expression and attenuate human tumor cell growth.

Cancer is a genomic functional disease with features of oncogene activation and tumor suppressor inactivation. These genomic features have resulted in the limited effectiveness of conventional therapies and therefore forced considerable efforts to explore new types of anticancer agents. It has been clear that chemically synthesized or in vivo-expressed short interfering RNA (siRNA) can specifically and effectively direct homology-dependent post-transcriptional gene silencing. In the present study, we intended to investigate whether siRNA could suppress the proliferation of human cancer cells through interfering oncogene activities and recovering the functions of tumor-suppressor gene. Single siRNA or combinatorial siRNAs were successfully transfected into HeLa cells, lung adenocarcinoma cells, hepatoma cells, ovarian carcinoma cells, and melanoma cells with cationic lipid complexes. These siRNA molecules not only specifically knocked down their cognate targets such as bcl-2, cdk-2, mdm-2, pkc-alpha, tgf-beta1, H-ras, vegf, and GFP mRNAs, but also effectively suppressed the proliferation of cancer cells to different extents. These data suggest that (1) all these human cancer cells preserve RNAi machinery; (2) chemically synthesized and vector-driven siRNAs can be incorporated into intrinsic RNAi system for silencing target mRNA molecules; and (3) the combination of different siRNAs inhibits the growth and proliferation of cancer cells.

[1]  U. Zangemeister‐Wittke,et al.  p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  A. Borkhardt,et al.  Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi) , 2002, Oncogene.

[3]  C. Poremba,et al.  Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression. , 1995, Oncology research.

[4]  Arndt Borkhardt,et al.  Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment? , 2002, Cancer cell.

[5]  F. McCormick,et al.  Opposing Effects of Ras on p53 Transcriptional Activation of mdm2 and Induction of p19ARF , 2000, Cell.

[6]  M. Dilber,et al.  Choosing CCR5 or Rev siRNA in HIV-1 , 2003, Nature Biotechnology.

[7]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[8]  R. Gaynor,et al.  Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference 1 , 2003 .

[9]  H. Kijima,et al.  Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. , 1996, Nucleic acids research.

[10]  P. Parker,et al.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. , 1995, The Journal of clinical investigation.

[11]  Y. Kondo,et al.  Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas. , 2001, International journal of oncology.

[12]  C. Rice,et al.  Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Dean,et al.  Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha. , 1998, Cancer letters.

[14]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[15]  C. Borner,et al.  Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice. , 1999, Melanoma research.

[16]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[17]  Y. Wan,et al.  RNA-mediated gene regulation system: now and the future (Review). , 2002, International journal of molecular medicine.

[18]  Ellen M. Langer,et al.  Bcl-xL Deamidation Is a Critical Switch in the Regulation of the Response to DNA Damage , 2002, Cell.

[19]  E. Lesnik,et al.  Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. , 2001, The Journal of pharmacology and experimental therapeutics.

[20]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[21]  P. Sharp,et al.  RNA interference--2001. , 2001, Genes & development.

[22]  D. Hinton,et al.  Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. , 2001, Blood.

[23]  L. Papucci,et al.  Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme , 2003, Cancer Gene Therapy.

[24]  Julian Peto,et al.  Cancer epidemiology in the last century and the next decade , 2001, Nature.

[25]  J. Hansson,et al.  Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic‐based population study , 1998 .

[26]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[27]  D. Weiss,et al.  Mutational analysis of the N-ras,p53,p16INK4a ,CDK4, and MC1R genes in human congenital melanocytic naevi , 1999, Journal of medical genetics.

[28]  S. Thomas,et al.  Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation. , 2001, Nucleic acids research.

[29]  A. Fire,et al.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Anastasia Khvorova,et al.  RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K Weber,et al.  Identification of essential genes in cultured mammalian cells using small interfering RNAs. , 2001, Journal of cell science.

[32]  S. Philippou,et al.  Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor. , 2001, Cancer research.

[33]  D. Chang,et al.  ARIA is concentrated in nerve terminals at neuromuscular junctions and at other synapses , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.